The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Virtual Reality Therapy Is Feasible for Rheumatology Patients

Virtual Reality Therapy Is Feasible for Rheumatology Patients

January 19, 2021 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Pilot Study

The team recruited 20 adult rheumatology patients from a private practice clinic in Los Angeles. The participants were primarily female and Caucasian. The most common diagnosis was rheumatoid arthritis, followed by lupus and fibromyalgia. All participants had active, but stable, disease. They all had some degree of ongoing pain as assessed by a score of at least 5 on the Visual Analog Scale (VAS) for at least four days of the preceding month. Most of the patients had some knowledge of VR prior to the study. Three participants were excluded due to medical conditions that might theoretically be aggravated by VR, such as vertigo.1

You Might Also Like
  • Make Rehab Fun: Virtual Reality & Therapeutic Gaming
  • Tech Talk: Smartphone Apps, Online Games May Encourage Healthy Behaviors in Rheumatology Patients
  • Rheumatology’s Virtual “Water Cooler”
Explore This Issue
January 2021
Also By This Author
  • PAD4 Antibodies May Help Predict Treatment Response in Rheumatoid Arthritis

All participants experienced two different VR environments: a guided meditation environment and a respiratory biofeedback environment. The latter provided interaction to help patients breathe at six breaths a minute. Some participants experienced the guided meditation environment first and others the biofeedback environment. Both modules provided immersive experiences in similar natural environments for 10–15 minutes.1 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The team also performed pre-VR, between VR and post-VR assessments using scales from the Patient-Reported Outcomes Measurement Information System (PROMIS), as well as the VAS. They also collected general impressions from the participants.1

“I would say that the main finding of the study was that this intervention was very well tolerated by 100% of the patients,” says Dr. Venuturupalli. Only one participant found the device uncomfortable, though 44% said they would prefer to use a lighter device. All said they would be willing to participate in another VR study.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The pilot project was not powered to draw definitive conclusions about effectiveness. However, about two-thirds of participants reported positive responses to at least one of their two VR sessions, and the researchers found a statistically significant reduction in VAS scores after both types of VR modules. Most patients said they could see themselves utilizing VR for relaxation and pain reduction if it were available to them.1

Looking Forward

Although much work remains to be done, Dr. Venuturupalli sees VR as a promising potential treatment modality that comes with very few risks. Since development of early VR systems, the technology has become less expensive, more portable and easier to use. Ultimately, Dr. Venuturupalli predicts that VR devices will become as ubiquitous as smartphones are today.

Many important research questions remain about how best to approach VR interventions. Dr. Venuturupalli points out that in addition to pain and anxiety reduction, VR may be used for instruction, such as teaching movement skills in elderly patients with osteo­arthritis. He notes that we need to learn about how best to dose VR in terms of how long and how often patients would use it, and how long the effects last. 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“What we need is some sort of virtual reality prescribing guide, where certain conditions are treated with certain kinds of protocols,” he says. “That will require a lot more research.” 

Dr. Venuturupalli notes that in addition to VR, other technologies, such as augmented reality and mixed reality, are being used for various medical purposes. Unlike VR, such technology does not place participants in a completely immersive environment. Instead, the external world is enhanced in particular ways to help patients build specific skills. 

The National Institutes of Health awarded Dr. Venuturupalli’s group a grant to study VR for back pain. The study will be led by Brennan Spiegel, MD. The team is also hoping to get more funding to research other aspects of the technology. The researchers would like to curate a library of VR programs that could target pain, anxiety, movement and sleep for patients with chronic rheumatic diseases. Rheumatologists could then prescribe specific interventions for their patients. 

“Down the road, the possible treatment interventions are innumerable,” Dr. Venuturupalli says.

For pain control, the need for new inter­ventions is more pressing than ever. As Dr. Venuturupalli points out, “The current opioid epidemic is making it necessary for the medical profession to find different ways to manage pain. But we don’t have very much guidance about what can work for our patients.” VR may represent one new potential tool in the pain treatment armamentarium.

Pages: 1 2 3 | Single Page

Filed Under: Research Reviews Tagged With: Chronic pain, meditation, Pain Management, Technology, virtual realityIssue: January 2021

You Might Also Like:
  • Make Rehab Fun: Virtual Reality & Therapeutic Gaming
  • Tech Talk: Smartphone Apps, Online Games May Encourage Healthy Behaviors in Rheumatology Patients
  • Rheumatology’s Virtual “Water Cooler”
  • Capitol Hill Rheumatology Advocacy Goes Virtual

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)